Feedback #FDBK – Interim Report for the six months ended 30 November 2017

Cambridge, UK – 26 February 2018: Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces its unaudited results for the six months ended 30 November 2017.  Operational highlights (including post-period end)1 ·      Exclusive TexRAD® distributor agreements signed in China and Korea ·      CE marked release of TexRAD® Lung ·      Three pilot TexRAD® Lung installations secured with existing research customers ·      Significant TexRAD® research […]

Feedback plc #FDBK – First CE marked release of TexRAD® technology

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces the first CE marked release of TexRAD®; the Company’s patented quantitative image texture analysis technology for diagnostic radiological scans. TexRAD® has the potential to assist clinicians in diagnosis, prognosis and treatment of patients with cancer and is currently installed in over 40 of the world’s […]

Feedback #FDBK – Final results, notice of AGM and TexRAD® Lung CE mark update.

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces its final results for the year ended 31 May 2017. Operational highlights (including post-period end)1 ·      Letter of Intent for TexRAD® Lung signed with a leading global medical imaging company ·      Exclusive TexRAD® distributor agreements signed in China and Korea ·      Prototype integration solution for TexRAD® demonstrated to Alliance Medical Group […]

Feedback (FDBK) subsidiary CCI signs exclusive agreement with Boya Digital Technology (Beijing) to distribute TexRAD in China

Feedback plc is pleased to announce that its subsidiary, Cambridge Computed Imaging Ltd, has signed an exclusive distributor agreement with Boya Digital Technology (Beijing) Co. Ltd., based in Beijing, China, for sales and distribution of its TexRAD® texture analysis research software in the People’s Republic of China. Boya is an approved vendor to GE Healthcare China, Beijing and is […]

Commercial Director appointed for CCI Ltd – Feedback (FDBK)

Feedback plc are pleased to welcome Ian McLellan as Commercial Director for CCI Ltd. This new role will develop the market and sales channels for our products, supporting sales growth including the launch of next generation TexRAD products as part our commitment to invest in our Brands. Ian has joined CCI after working closely with […]

Feedback (FDBK) subsidiary Cambridge Computed Imaging announces exclusive distributor arrangement with Korea Computer Motion ISG

Feedback plc subsidiary Cambridge Computed Imaging Ltd (CCI) is pleased to announce the signing of an Exclusive Distributor arrangement with Korea Computer Motion ISG (Korea ISG) based in Seoul, South Korea for sales and distribution of its TexRAD® texture analysis research software.  TexRAD will be used by customers for research purposes, performing advanced analysis of […]

Feedback (FDBK) – Progress with CE mark and trading update

Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders on obtaining the CE Mark for TexRAD. The Group had previously announced its expectation of obtaining the CE mark for TexRAD Lung by a target date of end May 2017.  In the course of development and review in compliance with ISO […]

Feedback Plc (FDBK) – Letter of Intent signed and trading update

Letter of Intent signed with leading global medical imaging company and trading update Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders on current developments. The Group’s efforts are being concentrated on obtaining the CE mark for TexRAD Lung by the target date of May 2017. The CE mark will […]

Feedback Plc (FDBK) – Interim Report for six months ended 30 November 2016

Feedback plc – Interim Report for the six months ended 30 November 2016 Chairman’s Statement We are pleased to present the interim results for the six months ended 30 November 2016. Revenue for the six months period was £203,000 (2015: £225,000) and the loss after tax was £126,000 (2015: Loss £143,000). The loss before interest, tax […]